Randomized Phase II Study of Weekly ABI-007 Plus Gemcitabine or Simplified LV5FU2 as First-line Therapy in Patients With Metastatic Pancreatic Cancer
Phase of Trial: Phase II
Latest Information Update: 07 Jan 2019
Price : $35 *
At a glance
- Drugs Paclitaxel (Primary) ; Fluorouracil; Folinic acid; Gemcitabine
- Indications Adenocarcinoma; Pancreatic cancer
- Focus Therapeutic Use
- Acronyms AFUGEM
- 30 Jan 2017 Planned End Date changed from 1 Jul 2016 to 1 Jul 2017.
- 30 Jan 2017 Planned primary completion date changed from 1 Jul 2016 to 1 Feb 2017.
- 10 Aug 2016 Status changed from active, no longer recruiting to completed according to the results presented at the 52nd Annual Meeting of the American Society of Clinical Oncology.